Debjit Chattopadhyay's Stock Ratings

Guggenheim Analyst

Debjit Chattopadhyay is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/22/2024

Overall Average Return

8.02%

Smart Score

63.1%

Overall Average Return Percentile

54th

Number of Ratings

34
Buy NowGet Alert
06/28/2024CRSPBuy Now
CRISPR Therapeutics
$55.00Assumes → NeutralGet Alert
05/14/2024FOLDBuy Now
Amicus Therapeutics
$10.3825.24% → $13UpgradeNeutral → BuyGet Alert
04/30/2024DTILBuy Now
Precision BioSciences
$10.4481.99% → $19Initiates → BuyGet Alert
04/18/2024VRTXBuy Now
Vertex Pharmaceuticals
$491.75-8.49%$445 → $450MaintainsBuyGet Alert
03/26/2024VYGRBuy Now
Voyager Therapeutics
$8.37162.84% → $22Initiates → BuyGet Alert
03/07/2024DYNBuy Now
Dyne Therapeutics
$41.47-10.78%$33 → $37MaintainsBuyGet Alert
03/05/2024PRMEBuy Now
Prime Medicine
$5.30277%$24 → $20MaintainsBuyGet Alert
02/27/2024KRYSBuy Now
Krystal Biotech
$203.66-14.07%$130 → $175MaintainsBuyGet Alert
01/18/2024NAMSBuy Now
NewAmsterdam Pharma
$18.9058.73% → $30Initiates → BuyGet Alert
11/21/2023SLNOBuy Now
Soleno Therapeutics
$46.96-14.82% → $40Assumes → BuyGet Alert
09/13/2023BMRNBuy Now
Biomarin Pharmaceutical
$84.0930.81% → $110ReiteratesBuy → BuyGet Alert
08/15/2023CNTABuy Now
Centessa Pharmaceuticals
$9.436.04%$9 → $10MaintainsBuyGet Alert
07/31/2023PRMEBuy Now
Prime Medicine
$5.30352.4% → $24Initiates → BuyGet Alert
06/12/2023CNTABuy Now
Centessa Pharmaceuticals
$9.43-4.56% → $9Initiates → BuyGet Alert
05/22/2023KRYSBuy Now
Krystal Biotech
$203.66-36.17%$101 → $130MaintainsBuyGet Alert
05/02/2023VRTXBuy Now
Vertex Pharmaceuticals
$491.75-21.71%$339 → $385MaintainsBuyGet Alert
04/27/2023BMRNBuy Now
Biomarin Pharmaceutical
$84.0942.7%$125 → $120MaintainsBuyGet Alert
02/28/2023QUREBuy Now
uniQure
$7.74584.75% → $53Reiterates → BuyGet Alert
02/28/2023KRYSBuy Now
Krystal Biotech
$203.66-50.41% → $101Reiterates → BuyGet Alert
02/28/2023BMRNBuy Now
Biomarin Pharmaceutical
$84.0948.65% → $125Reiterates → BuyGet Alert
01/26/2023DYNBuy Now
Dyne Therapeutics
$41.47-20.42% → $33Initiates → BuyGet Alert
11/21/2022ALLOBuy Now
Allogene Therapeutics
$2.85917.54%$43 → $29MaintainsBuyGet Alert
11/11/2022PASGBuy Now
Passage Bio
$0.861177.29%$13 → $11MaintainsBuyGet Alert
10/13/2022RAREBuy Now
Ultragenyx Pharmaceutical
$42.5517.51% → $50UpgradeNeutral → BuyGet Alert
06/27/2022ALNYBuy Now
Alnylam Pharmaceuticals
$237.83DowngradeBuy → NeutralGet Alert
03/01/2022IONSBuy Now
Ionis Pharmaceuticals
$47.8233.84% → $64Initiates → BuyGet Alert
01/31/2022SRRABuy Now
Sierra Oncology
$35 → $51MaintainsBuyGet Alert
01/05/2022BEAMBuy Now
Beam Therapeutics
$26.00400% → $130Initiates → BuyGet Alert
12/16/2021TSHABuy Now
Taysha Gene Therapies
$2.141208.41%Initiates → BuyGet Alert
12/01/2021VRTXBuy Now
Vertex Pharmaceuticals
$491.75-41.84%$250 → $286MaintainsBuyGet Alert
06/01/2021TALSBuy Now
Talaris Therapeutics
→ $260Initiates → BuyGet Alert
03/31/2020AVROBuy Now
Avrobio
$420 → $156DowngradeBuy → NeutralGet Alert
03/11/2020DTILBuy Now
Precision BioSciences
$10.4481.99%$630 → $570MaintainsBuyGet Alert
09/17/2018AVROBuy Now
Avrobio
→ $564Initiates → BuyGet Alert
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free